COMMUNIQUÉS West-GlobeNewswire

CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado
10/04/2019
Acquisition further strengthens medical cannabis data company’s financial metrics and data asset; reaching more than 85,000 patient evaluations per year TORONTO, April 10, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or [...]
Ravenquest Provides Update on Recent License and Production Capacity Expansion
10/04/2019
VANCOUVER, British Columbia, April 10, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally licensed producer of cannabis, is pleased to [...]
Professor Alvaro Pascual-Leone joins Nexstim Scientific Advisory Board
10/04/2019
Press release, Helsinki, 10 April 2019 at 9.00 am (EET) Professor Alvaro Pascual-Leone joins Nexstim Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
Centauri Therapeutics to present at 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
10/04/2019
Centauri Therapeutics to present at 29 th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) UK, 10 April 2019: Centauri Therapeutics (“Centauri”), an immunotherapy company active in oncology [...]
Oasmia expands the Management Team
10/04/2019
Oasmia Pharmaceutical AB (NASDAQ: OASM) expands the Management Team in order to directly involve the whole organization in the commercialization of Apealea and other product candidates. Earlier the Management Team was [...]
EssilorLuxottica: 2018 Registration Document Filed
10/04/2019
2018 Registration Document Filed Charenton-Le-Pont, France (April 10, 2019 – 8:00 am CEST) – The 2018 EssilorLuxottica Registration Document was filed in French version with the Autorité des Marchés Financiers (AMF) on [...]
EssilorLuxottica : Mise à disposition du Document de référence 2018
10/04/2019
Mise à disposition du Document de référence 2018 Charenton-le-Pont, France (le 10 avril 2019 – 8h00) - Le Document de référence 2018 d’EssilorLuxottica a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 9 [...]
William Demant Holding A/S: Investor news - Demant is bringing Philips hearing aids to market
10/04/2019
Investor news 10 April 2019 Demant is bringing Philips hearing aids to market Hearing aid users can now choose solutions from the Philips brand portfolio, one of the world’s best known and leading health technology [...]
Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA
10/04/2019
SHANGHAI, China and ROCKVILLE, Md., April 09, 2019 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics (ICT), a biotechnology company developing cellular immunotherapies for the treatment of cancer, today announced it [...]
Homology Medicines Announces Pricing of Public Offering of Common Stock
10/04/2019
BEDFORD, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common [...]
New York Threatens Prison for Vaccine Refusal, States Association of American Physicians and Surgeons (AAPS)
10/04/2019
TUCSON, Ariz., April 09, 2019 (GLOBE NEWSWIRE) -- According to an order signed today by Oxiris Barbot, M.D., New York City Commissioner of Health, all persons, adults or children, who live, work, or reside in 11205, [...]
Guardant Health Announces Commercial Payer Progress with more than 150 Million Lives Covered for Guardant360
09/04/2019
REDWOOD CITY, Calif., April 09, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that its market leading liquid biopsy, Guardant360®, will be a covered benefit for the members of the health plans [...]
PhaseBio Announces Proposed Public Offering of Common Stock
09/04/2019
MALVERN, Pa. and SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Dentsply Sirona to Host First Quarter 2019 Conference Call on May 3rd
09/04/2019
YORK, Pa., April 09, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Friday, May 3, [...]
Integra LifeSciences to Host First Quarter 2019 Earnings Results Conference Call on April 24, 2019
09/04/2019
PLAINSBORO, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2019 financial results on Wednesday [...]
PCI Biotech: Annual Report 2018
09/04/2019
Oslo, Norway, April 9, 2019 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2018 and the report is attached. The Annual Report 2018 is also available on the company’s website www. [...]
Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress
09/04/2019
GAITHERSBURG, Md., April 09, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that Gregory M. Glenn, M.D., President of Research and Development, will share data from its global Phase 3 clinical [...]
PRA Health Sciences to Report First Quarter 2019 Earnings
09/04/2019
RALEIGH, N.C., April 09, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2019 results after the market closes on Wednesday, May 1, 2019. The Company will also host a [...]
OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
09/04/2019
Cover therapeutic applications of FR104 through 2031 In Canada and in the U.S. in autoimmune diseases, chronic inflammatory diseases and graft applications NANTES, France, April 09, 2019 (GLOBE NEWSWIRE) -- OSE [...]

Pages